Experience of transcatheter device closure of atrial septal defect in a tertiary care institute

Muhammad Younas1, Ahsan Beg2, Tauseef Asma2

  • 1Department of Paediatric Cardiology, Chaudhry Pervaiz Elahi Institute of Cardiology, Multan.

Insights

Transcatheter device closure is a safe and effective treatment for secundum atrial septal defects in both children and adults. This study demonstrated a high success rate with minimal complications in 75 patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Paediatric Cardiology

Background:

  • Secundum atrial septal defect (ASD) is a common congenital heart condition.
  • Transcatheter device closure offers a minimally invasive alternative to surgical repair.
  • Institutional experience with this procedure in a diverse age group is valuable.

Purpose of the Study:

  • To evaluate the institutional experience with transcatheter device closure of secundum ASD.
  • To assess the safety and efficacy of this procedure in children and adults.
  • To report outcomes in patients with moderate to large ASDs.

Main Methods:

  • A descriptive cross-sectional study of 75 patients with moderate to large secundum ASD.
  • Procedures performed under general anaesthesia with trans-oesophageal echo guidance.
  • Data collected on patient demographics, defect size, device type, and procedural outcomes.

Main Results:

  • The study included 75 patients (mean age 25 years; range 4-54 years) with ASDs (mean defect size 20.38mm).
  • The Amplatzer septal occluder was the most common device used (80%).
  • Overall procedural success was 97.3%, with no procedure-related mortality; transient arrhythmias and pericardial effusion were the main complications.

Conclusions:

  • Transcatheter device closure is a safe and effective treatment for moderate to large secundum ASD in children and adults.
  • The procedure has a high success rate and a low complication profile.
  • This approach provides a viable alternative to surgical intervention.
Abstract